The testing that is being performed by Wimbledon Health Partners gives us the clinical information to make judgment calls on each athlete during the course of competition.
Boca Raton, FL (PRWEB) October 01, 2014
Wimbledon Health Partners, an on-site diagnostic testing company that provides physicians vascular, echocardiogram and NCV testing with state-of-the-art in-office testing procedures, is proud to be the preferred diagnostic testing provider for young athletes at The University of Louisiana at Monroe (ULM), a coeducational public university in Monroe, Louisiana.
The diagnostic tests performed on-site at ULM include a non-invasive vascular ultrasound and echocardiogram, testing for underlying symptoms of Marfan syndrome and sudden cardiac arrest – the leading cause of death among young athletes. The tests also eliminate false positives that can deem athletes ineligible to play. To date, Wimbledon Health Partners has tested ULM’s women’s volleyball and sand volleyball teams as well as the men’s basketball team.
On-site diagnostic testing is convenient for athletes at ULM because appointments are booked around class and training schedules, and testing is performed in familiar surroundings – minimizing stress and anxiety. Most importantly, athletes (and their coaches) know exactly where they stand health-wise, getting back in the game healthy and ready to compete.
“The testing that is being performed by Wimbledon Health Partners gives us the clinical information to make judgment calls on each athlete during the course of competition. Oftentimes, our athletic trainers are forced to make on-the-spot decisions to determine if an athlete is experiencing dehydration or a cardiac event, which can mimic each other. With Wimbledon, we have been able to establish a medical baseline on our student athletes,” commented Jeremy Teblum, Staff Athletic Trainer.
Current NCAA guidelines require CPR, first aid and automated external defibrillator training for coaches, and recommend athletes be tested for cardiovascular health. The primary purpose of pre-participation testing is to identify athletes affected by unsuspected cardiovascular diseases and to prevent sudden cardiac death (SCD) during sports by appropriate interventions. The American College of Cardiology (ACC) states that the ultimate goal of athletic testing is the detection of silent cardiovascular abnormalities that can lead to SCD.
Plans for Wimbledon Health Partners to provide on-site diagnostic testing at additional NCAA universities across the country are in development. For more information, or to learn how to become a national Affiliate with Wimbledon Health Partners, please call (855) 200-8262 or visit http://www.dxtesting.com.
About Wimbledon Health Partners
Wimbledon Health Partners is a national on-site diagnostic testing organization with capabilities for diagnosing circulatory conditions that can be detected through the use of cardiovascular ultrasound and echocardiogram. Additional capabilities include nerve conduction velocity testing (NCV), which is utilized to support the diagnosis of nerve involvement of circulatory disease, and help assess cardiovascular risk. Wimbledon Health Partners provides an innovative cooperative marketing and practice-enhancement program to physicians with the educational, compliance, and marketing tools necessary to deliver quality, state-of-the-art in-office testing procedures. For more information, visit http://www.dxtesting.com or call (855) 200-8262.